Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome

Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome

Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality, however with no effective therapy available. Methods: The effect of favipiravir (FPV) in treating SFTS was evaluated by an integrated analysis on data collected from a single-arm stu...

Full description

Bibliographic Details
Main Authors: Yang Yuan, Qing-Bin Lu, Wen-Si Yao, Jing Zhao, Xiao-Ai Zhang, Ning Cui, Chun Yuan, Tong Yang, Xue-Fang Peng, Shou-Ming Lv, Jia-Chen Li, Ya-Bin Song, Dong-Na Zhang, Li-Qun Fang, Hong-Quan Wang, Hao Li, Wei Liu
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EBioMedicine
Subjects:
Severe fever with thrombocytopenia syndrome
Favipiravir
Efficacy
Safety
Heterogeneity
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003844

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421003844

Similar Items